Jeff Tangney, CEO, of Doximity at the New York Stock Exchange for their IPO, June 24, 2021. Source: NYSE Jeff Tangney launched his first health-tech start-up, Epocrates, in the middle of the dot-com bubble. While the company survived the crash and eventually went public, the endgame was a disappointing acquisition for less than $300 million. […]
By David Peck, Ph.D. Great abs are on the “most wanted” list for many of us this summer, yet you see so few people with mind-blowing six-packs. Unfortunately, the avenue to amazing abs is cluttered with training evangelism, and everyone has his own opinion, technique or idea about how to best train this often troublesome […]
There may soon be a vaccine available that blocks the addictive euphoric and harmful effects of opioid use. The vaccine is entering a phase I clinical trial, the first human-tested clinical trial of this type of vaccine.1 Developed by researchers at the University of Minnesota, the vaccine may help alleviate the opioid overdose crisis; in […]
